Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2022 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/51521 |
Resumo: | We thank the study participants. We also thank the teams of clinical and laboratory platforms of RePORT-Brazil. A special thanks to Elze Leite (FIOCRUZ, Salvador, Brazil), Eduardo Gama (FIOCRUZ, Rio de Janeiro, Brazil), Elcimar Junior (FMT-HVD, Manaus, Brazil), and Hilary Vansell (VUMC, Nashville, USA) for administrative and logistical support. |
| id |
CRUZ_5775f3b0f9ce70cea0f913ca674fa208 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/51521 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Arriaga, María B.Pereira, Mariana AraújoDuarte, Beatriz BarretoSales, CaioPinto, João Pedro MiguezNogueira, Evelyn B.Nogueira, Betânia M. F.Rocha, Michael S.Souza, Alexandra B.Benjamin, AlineOliveira, Jamile G. deMoreira, Adriana S. R.Queiroz, Artur T. L.Rodrigues, Moreno M. S.Gomes, Renata SpenerFigueiredo, Marina C.Durovni, BetinaCavalcante, SolangeSilva, José R. Lapa eKristki, Afrânio L.Santos, Marcelo CordeiroSterling, Timothy R.Rolla, Valeria C.Andrade, Bruno B.2022-03-03T16:41:43Z2022-03-03T16:41:43Z2022ARRIAGA, María B. et al. Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil. Frontiers in Medicine, v. 8, n. 804173, p. 1-12, 21 Jan. 2022.2296-858Xhttps://www.arca.fiocruz.br/handle/icict/5152110.3389/fmed.2021.8041732296-858XWe thank the study participants. We also thank the teams of clinical and laboratory platforms of RePORT-Brazil. A special thanks to Elze Leite (FIOCRUZ, Salvador, Brazil), Eduardo Gama (FIOCRUZ, Rio de Janeiro, Brazil), Elcimar Junior (FMT-HVD, Manaus, Brazil), and Hilary Vansell (VUMC, Nashville, USA) for administrative and logistical support.Pesquisa Intramuros Programa da FIOCRUZ (BA.). Fogarty International Center e Instituto Nacional de Saúde Infantil e Desenvolvimento Humano dos Institutos Nacionais de Saúde. Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB). Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.Intramural research program of FIOCRUZ (BA.)Fogarty International Center and National Institute of Child Health & Human Development of the National Institutes of Health under (Award Number D43 TW009763NIH (U01AI069923)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), BrazilFundação de Amparo à Pesquisa do Estado da Bahia (FAPESB), BrazilCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance code: 001)Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Salvador. Escola de Medicina. Salvador, BA, Brasil / Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Programa de Pós-Graduação em Clínica Médica. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Salvador. Escola de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Salvador. Escola de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Salvador. Escola de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil / Fundação José Silveira. Instituto Brasileiro para Investigação de Tuberculose. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Fundação José Silveira. Instituto Brasileiro para Investigação de Tuberculose. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, BA, Brasil.Fundação de Medicina Tropical Doutor Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Programa de Pós-Graduação em Medicina Tropical. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Micobacterioses. Rio de Janeiro, RJ, Brasil.Prefeitura da Cidade do Rio de Janeiro. Secretaria Municipal de Saúde. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Instituto de Doenças do Tórax. Programa Acadêmico de Tuberculose. Rio de Janeiro, RJ, Brasil.Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimentos para Saúde. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Fiocruz Rondônia. Laboratório de Análise e Visualização de Dados. Porto Velho, RO, Brasil.Fundação de Medicina Tropical Doutor Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Programa de Pós-Graduação em Medicina Tropical. Manaus, AM, Brasil.Vanderbilt University School of Medicine. Department of Medicine. Division of Infectious Diseases. Nashville, TN, United States of America.Prefeitura da Cidade do Rio de Janeiro. Secretaria Municipal de Saúde. Rio de Janeiro, RJ, Brasil.Prefeitura da Cidade do Rio de Janeiro. Secretaria Municipal de Saúde. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Instituto de Doenças do Tórax. Programa Acadêmico de Tuberculose. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Faculdade de Medicina. Instituto de Doenças do Tórax. Programa Acadêmico de Tuberculose. Rio de Janeiro, RJ, Brasil.Fundação de Medicina Tropical Doutor Heitor Vieira Dourado. Manaus, AM, Brasil / Universidade do Estado do Amazonas. Programa de Pós-Graduação em Medicina Tropical. Manaus, AM, Brasil / Universidade Nilton Lins. Faculdade de Medicina. Manaus, AM, Brasil.Vanderbilt University School of Medicine. Department of Medicine. Division of Infectious Diseases. Nashville, TN, United States of America.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Micobacterioses. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Inflamação e Biomarcadores. Salvador, BA, Brasil / Multinational Organization Network Sponsoring Translational and Epidemiological Research. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil / Universidade Salvador. Escola de Medicina. Salvador, BA, Brasil / Vanderbilt University School of Medicine. Department of Medicine. Division of Infectious Diseases. Nashville, TN, United States of America.Background: There are scarce data on the prevalence and disease presentation of HIV in patients with tuberculosis (TB) and dysglycemia (diabetes [DM] and prediabetes [PDM]), especially in TB-endemic countries. Methods: We assessed the baseline epidemiological and clinical characteristics of patients with culture-confirmed pulmonary TB, enrolled in a multicenter prospective cohort in Brazil (RePORT-Brazil) during 2015–2019. Dysglycemia was defined by elevated glycated hemoglobin and stratified as PDM or DM. Additionally, we used data from TB cases obtained through the Brazilian National Notifiable Diseases Information System (SINAN), during 2015–2019. In SINAN, diagnosis of diabetes was based on self-report. Logistic regression models were performed to test independent associations between HIV, dysglycemia status, and other baseline characteristics in both cohorts. Results: In the RePORT-Brazil cohort, the prevalence of DM and of PDM was 23.7 and 37.8%, respectively. Furthermore, the prevalence of HIV was 21.4% in the group of persons with TB-dysglycemia and 20.5% in that of patients with TBDM. In the SINAN cohort, the prevalence of DM was 9.2%, and among the TBDM group the prevalence of HIV was 4.1%. Logistic regressions demonstrated that aging was independently associated with PDM or DM in both the RePORT-Brazil and SINAN cohorts. In RePORTBrazil, illicit drug use was associated with PDM, whereas a higher body mass index (BMI) was associated with DM occurrence. Of note, HIV was not associated with an increased risk of PDM or DM in patients with pulmonary TB in both cohorts. Moreover, in both cohorts, the TBDM-HIV group presented with a lower proportion of positive sputum smear and a higher frequency of tobacco and alcohol users. Conclusion: There is a high prevalence of dysglycemia in patients with pulmonary TB in Brazil, regardless of the HIV status. This reinforces the idea that DM should be systematically screened in persons with TB. Presence of HIV does not substantially impact clinical presentation in persons with TBDM, although it is associated with more frequent use of recreational drugs and smear negative sputum samples during TB screening.engFrontiers MediaDisglicemiaInfecção pelo HIVTuberculose pulmonarMycobacterium tuberculosisDiabetesDysglycemiaHIV infectionPulmonary tuberculosisMycobacterium tuberculosisDiabetesDisglucemiaInfección por VIHTuberculosisMycobacterium tuberculosisDiabetesDysglycémieL'infection par le VIHTuberculoseMycobacterium tuberculosisLe diabèteTuberculose PulmonarMycobacterium tuberculosisDiabetes MellitusPrevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/51521/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALArriaga, M.B. Prevalence and Clinical....pdfArriaga, M.B. Prevalence and Clinical....pdfapplication/pdf4388780https://www.arca.fiocruz.br/bitstream/icict/51521/2/Arriaga%2c%20M.B.%20Prevalence%20and%20Clinical....pdf04b0c017f7b7e1412f55c3e37bd3fea3MD52icict/515212023-03-15 14:33:11.949oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:11Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.en_US.fl_str_mv |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| title |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| spellingShingle |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil Arriaga, María B. Disglicemia Infecção pelo HIV Tuberculose pulmonar Mycobacterium tuberculosis Diabetes Dysglycemia HIV infection Pulmonary tuberculosis Mycobacterium tuberculosis Diabetes Disglucemia Infección por VIH Tuberculosis Mycobacterium tuberculosis Diabetes Dysglycémie L'infection par le VIH Tuberculose Mycobacterium tuberculosis Le diabète Tuberculose Pulmonar Mycobacterium tuberculosis Diabetes Mellitus |
| title_short |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| title_full |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| title_fullStr |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| title_full_unstemmed |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| title_sort |
Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil |
| author |
Arriaga, María B. |
| author_facet |
Arriaga, María B. Pereira, Mariana Araújo Duarte, Beatriz Barreto Sales, Caio Pinto, João Pedro Miguez Nogueira, Evelyn B. Nogueira, Betânia M. F. Rocha, Michael S. Souza, Alexandra B. Benjamin, Aline Oliveira, Jamile G. de Moreira, Adriana S. R. Queiroz, Artur T. L. Rodrigues, Moreno M. S. Gomes, Renata Spener Figueiredo, Marina C. Durovni, Betina Cavalcante, Solange Silva, José R. Lapa e Kristki, Afrânio L. Santos, Marcelo Cordeiro Sterling, Timothy R. Rolla, Valeria C. Andrade, Bruno B. |
| author_role |
author |
| author2 |
Pereira, Mariana Araújo Duarte, Beatriz Barreto Sales, Caio Pinto, João Pedro Miguez Nogueira, Evelyn B. Nogueira, Betânia M. F. Rocha, Michael S. Souza, Alexandra B. Benjamin, Aline Oliveira, Jamile G. de Moreira, Adriana S. R. Queiroz, Artur T. L. Rodrigues, Moreno M. S. Gomes, Renata Spener Figueiredo, Marina C. Durovni, Betina Cavalcante, Solange Silva, José R. Lapa e Kristki, Afrânio L. Santos, Marcelo Cordeiro Sterling, Timothy R. Rolla, Valeria C. Andrade, Bruno B. |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Arriaga, María B. Pereira, Mariana Araújo Duarte, Beatriz Barreto Sales, Caio Pinto, João Pedro Miguez Nogueira, Evelyn B. Nogueira, Betânia M. F. Rocha, Michael S. Souza, Alexandra B. Benjamin, Aline Oliveira, Jamile G. de Moreira, Adriana S. R. Queiroz, Artur T. L. Rodrigues, Moreno M. S. Gomes, Renata Spener Figueiredo, Marina C. Durovni, Betina Cavalcante, Solange Silva, José R. Lapa e Kristki, Afrânio L. Santos, Marcelo Cordeiro Sterling, Timothy R. Rolla, Valeria C. Andrade, Bruno B. |
| dc.subject.other.pt_BR.fl_str_mv |
Disglicemia Infecção pelo HIV Tuberculose pulmonar Mycobacterium tuberculosis Diabetes |
| topic |
Disglicemia Infecção pelo HIV Tuberculose pulmonar Mycobacterium tuberculosis Diabetes Dysglycemia HIV infection Pulmonary tuberculosis Mycobacterium tuberculosis Diabetes Disglucemia Infección por VIH Tuberculosis Mycobacterium tuberculosis Diabetes Dysglycémie L'infection par le VIH Tuberculose Mycobacterium tuberculosis Le diabète Tuberculose Pulmonar Mycobacterium tuberculosis Diabetes Mellitus |
| dc.subject.en.en_US.fl_str_mv |
Dysglycemia HIV infection Pulmonary tuberculosis Mycobacterium tuberculosis Diabetes |
| dc.subject.es.es_ES.fl_str_mv |
Disglucemia Infección por VIH Tuberculosis Mycobacterium tuberculosis Diabetes |
| dc.subject.fr.fr_FR.fl_str_mv |
Dysglycémie L'infection par le VIH Tuberculose Mycobacterium tuberculosis Le diabète |
| dc.subject.decs.pt_BR.fl_str_mv |
Tuberculose Pulmonar Mycobacterium tuberculosis Diabetes Mellitus |
| description |
We thank the study participants. We also thank the teams of clinical and laboratory platforms of RePORT-Brazil. A special thanks to Elze Leite (FIOCRUZ, Salvador, Brazil), Eduardo Gama (FIOCRUZ, Rio de Janeiro, Brazil), Elcimar Junior (FMT-HVD, Manaus, Brazil), and Hilary Vansell (VUMC, Nashville, USA) for administrative and logistical support. |
| publishDate |
2022 |
| dc.date.accessioned.fl_str_mv |
2022-03-03T16:41:43Z |
| dc.date.available.fl_str_mv |
2022-03-03T16:41:43Z |
| dc.date.issued.fl_str_mv |
2022 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
ARRIAGA, María B. et al. Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil. Frontiers in Medicine, v. 8, n. 804173, p. 1-12, 21 Jan. 2022. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/51521 |
| dc.identifier.issn.pt_BR.fl_str_mv |
2296-858X |
| dc.identifier.doi.pt_BR.fl_str_mv |
10.3389/fmed.2021.804173 |
| dc.identifier.eissn.pt_BR.fl_str_mv |
2296-858X |
| identifier_str_mv |
ARRIAGA, María B. et al. Prevalence and clinical profiling of dysglycemia and HIV infection in persons with pulmonary tuberculosis in Brazil. Frontiers in Medicine, v. 8, n. 804173, p. 1-12, 21 Jan. 2022. 2296-858X 10.3389/fmed.2021.804173 |
| url |
https://www.arca.fiocruz.br/handle/icict/51521 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Frontiers Media |
| publisher.none.fl_str_mv |
Frontiers Media |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/51521/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/51521/2/Arriaga%2c%20M.B.%20Prevalence%20and%20Clinical....pdf |
| bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 04b0c017f7b7e1412f55c3e37bd3fea3 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1813009067525799936 |